Welcome to our dedicated page for Select Medical news (Ticker: SEM), a resource for investors and traders seeking the latest updates and insights on Select Medical stock.
Overview
Select Medical Holdings Corporation (NYSE: SEM) is a prominent healthcare organization that provides a full continuum of care with a focus on critical illness recovery, rehabilitation, and occupational health services. With a proven track record of clinical quality and operational excellence, Select Medical has built a robust platform in the United States by offering specialized medical recovery solutions and health services. The organization is characterized by its diverse network of facilities and its commitment to delivering patient-first care.
Business Segments and Services
Select Medical operates through four key segments that define its comprehensive service offerings:
- Critical Illness Recovery Hospitals: These facilities cater to patients who have emerged from life-threatening conditions and require extended support to regain their health. They focus on advanced medical care and prolonged recovery services.
- Rehabilitation Hospitals: Designed for inpatient care, these hospitals offer specialized therapies and medical oversight to patients recovering from strokes, spinal cord injuries, brain injuries, orthopedic conditions, and other complex health events.
- Outpatient Rehabilitation Clinics: Through a large network of clinics, Select Medical provides accessible outpatient rehabilitation services encompassing physical therapy, occupational therapy, and specialized recovery programs.
- Occupational Health Centers (Concentra): Focused on workplace and direct-to-employer care, the Concentra segment provides preventive health screenings, injury care, and comprehensive occupational medicine services to support the health and productivity of the workforce.
Operational Excellence and Clinical Commitment
The company maintains its founding principles by emphasizing clinical quality and a patient-first philosophy. Every facility within the Select Medical network reflects the company's core values by striving for optimal patient outcomes and compassionate care. With a strong emphasis on operational efficiency, clinical partnerships, and continuous improvement, Select Medical ensures that every stage of the care journey—from the acute recovery phase to outpatient follow-up—is managed with precision and expertise.
Market Position and Competitive Landscape
In a competitive healthcare market, Select Medical distinguishes itself through its expansive network and integration of recovery and rehabilitation services. The combination of inpatient facilities and outpatient care centers allows Select Medical to offer a seamless continuum of services that meet the diverse needs of patients across the United States. The company's strategic focus on quality, safety, and outcomes underscores its position as a major player in the post-acute care sector. Furthermore, its dedicated approach to recruiting and training top healthcare professionals fortifies its reputation for exceptional care delivery.
Partnerships and Innovative Care Delivery
Select Medical has cultivated numerous joint ventures and partnerships with established healthcare institutions, enhancing its capacity to introduce innovative care models and specialized programs. For instance, collaborations with renowned medical centers underline the company's commitment to integrating advanced technologies and evidence-based practices into its clinical programs. These partnerships not only drive operational improvements but also pave the way for enhanced patient experiences and long-term health benefits.
Commitment to Quality and Community Impact
The foundation of Select Medical's operational strategy lies in its unwavering commitment to improving quality of life. The company’s patient-centric approach is evident in its comprehensive care programs, which are tailored to meet individual recovery needs and promote long-term wellness. Additionally, Select Medical’s extensive presence across multiple states and its continuous investment in clinical excellence underscore its dedication to serving communities and addressing the dynamic healthcare needs of a diverse patient population.
Conclusion
Overall, Select Medical Holdings Corporation exemplifies a robust healthcare model that integrates a variety of post-acute services across critical illness recovery, inpatient and outpatient rehabilitation, and occupational health. Its strategic organization, combined with an evergreen commitment to clinical quality, positions it as a vital component of the U.S. healthcare landscape. This detailed overview serves as a comprehensive resource that encapsulates the company's operational frameworks, industry expertise, and dedication to delivering quality care.
Select Medical Holdings Corporation (NYSE: SEM) reported a 1.3% increase in revenue to $1,584.7 million for Q2 2022, but a substantial decline in income from operations, down to $121.0 million from $284.0 million year-over-year. Net income fell to $66.3 million from $196.2 million in the same quarter last year. A cash dividend of $0.125 per share was declared, payable on September 2, 2022. Select Medical reaffirmed its 2022 revenue outlook of $6.25 billion to $6.40 billion.
Select Medical announced that four of its inpatient rehabilitation hospitals have been recognized as the best in the U.S. for 2022-2023 by U.S. News & World Report. The Kessler Institute for Rehabilitation in New Jersey secured the No. 4 position, marking its 30th consecutive year on the list. Other honorees include Baylor Scott & White Institute, Emory Rehabilitation Hospital, and OhioHealth Rehabilitation Hospital. This recognition highlights Select Medical's commitment to clinical excellence and quality patient care.
Select Medical Holdings Corporation (NYSE: SEM) will announce its second quarter financial results for the period ending June 30, 2022, on August 4, 2022, after market close. A conference call discussing these results and the company's business outlook is scheduled for August 5, 2022, at 9:00 AM ET, accessible via their website. As of June 30, 2022, the company operates 105 critical illness recovery hospitals, 31 rehabilitation hospitals, and 1,920 outpatient rehabilitation clinics across several states, making it one of the largest operators in its field.
Select Medical Corporation and Inova Health System have announced a partnership to establish the first critical illness recovery hospital in Northern Virginia. This 32-bed facility, set to open in the first half of 2023 within Inova Mount Vernon Hospital, aims to provide essential post-acute care for patients recovering from serious illnesses. By integrating services from all five Inova hospitals, the new hospital will improve patient transitions and long-term outcomes, fulfilling a critical healthcare need in the region.
Select Medical and ShorePoint Health Venice announced a joint venture to operate a critical illness recovery and inpatient rehabilitation hospital in Venice, Florida. The new facility, branded Select Specialty Hospital – Venice, will feature 25 critical illness recovery beds and 28 inpatient rehabilitation beds. Renovations are set to begin this summer, with an anticipated opening in Q1 2023. This partnership aims to enhance specialty care for high acuity patients in the region and expands Select Medical’s presence in Florida, where it currently operates 12 critical illness recovery hospitals and 2 rehabilitation hospitals.
On May 5, 2022, Select Medical Holdings Corporation (NYSE: SEM) reported a 3.4% increase in revenue to $1,599.5 million for Q1 2022, while net income fell to $55.9 million from $137.2 million year-over-year. Income from operations decreased to $104 million, influenced by the prior year's CARES Act payments. The company declared a cash dividend of $0.125 per share, payable June 1, 2022. Select Medical reaffirmed its 2022 revenue outlook of $6.25 billion to $6.40 billion and plans to continue stock repurchases, having bought back 2.1 million shares at $51.7 million in Q1.
Select Medical announced plans to open a new 31-bed critical illness recovery hospital branded as Select Specialty Hospital – Oregon in early 2023. This facility will be located at Mercy Health - St. Charles Hospital in Ohio and will serve as a satellite of the existing Regency Hospital Toledo, which will be renamed Select Specialty Hospital – Toledo. With this expansion, Select Medical aims to enhance access to specialized post-acute care for patients in northern Ohio, providing a combined capacity of 76 beds in the region.
Select Medical Holdings Corporation (NYSE: SEM) is set to release its first-quarter financial results on May 5, 2022, after market close. A conference call to discuss these results and the company's outlook will take place on May 6, 2022, at 9:00 am ET. Select Medical operates a substantial network of healthcare facilities, including 104 critical illness recovery hospitals and 1,881 outpatient rehabilitation clinics as of December 31, 2021. For more information, visit www.selectmedical.com.
Select Medical Holdings Corporation (SEM) announced its Q4 and full year 2021 results, reporting a 6.8% revenue increase to $1.56 billion in Q4 and a 12.2% increase to $6.20 billion for the year. However, income from operations declined to $77.5 million in Q4 from $163.3 million a year prior, with net income falling from $102.2 million to $66.3 million. Adjusted EBITDA also decreased to $138.4 million in Q4, compared to $221.3 million a year earlier. The board declared a cash dividend of $0.125 per share, payable on March 16, 2022.
Select Medical Holdings Corporation (NYSE: SEM) announced estimated results for the year ending December 31, 2021, projecting net operating revenue around $6,204 million and Adjusted EBITDA at approximately $947 million. Earnings per share are expected to be between $2.90 and $2.92. The company faced significant labor cost increases in its critical illness recovery segment, impacting financial results adversely. Actual results will be disclosed on February 24, 2022, with a conference call scheduled for February 25, 2022, to discuss these results and future outlook.